American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 8(58), p. 4957-4960, 2014
DOI: 10.1128/aac.02350-14
Full text: Download
ABSTRACT Stable resistance to metronidazole in a nontoxigenic Clostridium difficile strain was investigated at both the genomic and proteomic levels. Alterations in the metabolic pathway involving the pyruvate-ferredoxin oxidoreductase were found, suggesting that reduction of metronidazole, required for its activity, may be less efficient in this strain. Proteomic studies also showed a cellular response to oxidative stress.